Translation. Region: Russian Federal
Source: People's Republic of China in Russian – People's Republic of China in Russian –
An important disclaimer is at the bottom of this article.
Source: People's Republic of China – State Council News
BEIJING, July 24 (Xinhua) — During the 14th Five-Year Plan period (2021-2025), Chinese authorities have taken a series of measures to ensure reasonable prices for medicines, Shi Zihai, deputy head of the National Medical Security Administration (NMSA), said on Thursday.
Shi Zihai presented the measures at a press conference held by the State Council Information Office.
According to him, since 2018, the country has conducted ten rounds of centralized procurement of medicines, covering 435 types of drugs. The centralized procurement program has become an effective means of curbing the overpricing of medicines, significantly alleviating the burden of the population in obtaining medicines, and also improving their quality and availability.
GUMO has also actively examined cases of improper pricing of medicines and called on the relevant pharmaceutical companies to correct their practices. To date, it has sent notices to 566 companies, requiring them to adjust prices for 726 medicines of different forms and specifications.
In addition, Shi Zihai said that measures have been taken to regulate prices of medicines both online and in regular pharmacies.
The official noted that some pharmaceutical companies, abusing their right to independent pricing, violated market order using methods such as offering kickbacks, monopolizing the market and controlling sales.
He assured that GUMO firmly supports and encourages medical innovation and high-quality development, respects the right of enterprises to independently set prices, and more effectively plays its role in managing drug pricing and maintaining normal market order. -0-
Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.
.